No description available.

Cardiac, metabolic and growth response of early-stage chicken embryos to perturbations in yolk environment was investigated. Also, effects of parental hypoxia exposure on hypoxia resistance, thermal tolerance and body length of zebrafish larvae were investigated. In the first study, thyroxine, triiodothyronine and testosterone produced differential effects on heart rate and development rate of chicken embryos during the first 4 days of development. Triiodothyronine caused a dose-dependent increase in heart rate when applied at 40 or 70 hours of age, while thyroxine caused a dose-dependent increase in heart rate when applied at 40 hours only. Testosterone and propyl-thiouracil (deiodinase antagonist) did not have an effect on heart rate. Development rate was not changed by thyroxine, triiodothyronine, testosterone or propyl-thiouracil, which suggested that heart rate changes did not result from changes in embryo maturity. In the second study, chicken embryos exposed to yolks of different bird species during early-stage embryonic development showed changes in heart rate, mass-specific oxygen consumption and body mass that scaled with the egg mass, incubation period length, and yolk triiodothyronine and testosterone levels of the species from which yolk was derived. In the third study, this phenomenon was investigated between layer and broiler chickens. Heart rate, oxygen consumption and body mass of broiler and layer embryos were significantly changed by a breed-specific change in yolk environment. Yolk triiodothyronine and testosterone concentrations of broiler and layer eggs did not suggest that these hormones were responsible for physiological and morphological changes observed. The final study demonstrated that hypoxia resistance and body lengths, but not thermal tolerance of zebrafish larvae was increased by parental hypoxia exposure.

O conteúdo de zinco (Zn) reativo cerebral é importante para o equilíbrio da sinaptofisiologia neural. A prova disto é que um aumento nos seus níveis, após evento hipóxico-isquêmico, resulta em neurotoxicidade, o que tem estimulado o tratamento desta disfunção cerebral com quelantes de Zn, tal como o dietilditiocarabamato (DEDTC). No caso do DEDTC, o uso deste composto sobre esta disfunção deve ser analisado com cuidado, pois ele também apresenta muitos efeitos colaterais sobre o sistema nervoso central. Desta forma, para atender este propósito, é necessário antes obter uma concentração de DEDTC com menores efeitos colaterais. Por esta razão, no presente trabalho, nós decidimos usar um modelo vertebrado mais simples, tal como o peixe-zebra, o qual permitiria a triagem, em larga escala, dos efeitos de DEDTC sobre o Zn reativo. Entretanto, jamais foi mostrada a presença de Zn reativo no cérebro de peixe-zebra. Com isto, através de marcações histológicas, nós conseguimos mostrar pela primeira vez a distribuição citoarquitectônica de Zn reativo em neurônios glutamatérgicos, bem como o número desses neurônios contendo Zn no cérebro de peixe-zebra. Isto nos permitiu avaliar o efeito de diferentes concentrações de DEDTC sobre o conteúdo de Zn cerebral do peixe-zebra, o qual foi intensamente quelado por elevadas quantidades do composto, induzindo comportamentos tipo-crise. Neste mesmo estudo nós obtemos também uma concentração de DEDTC com poucos efeitos colaterais que poderia exercer neuroproteção sobre o aumento de Zn reativo induzido pela hipóxia-isquemia. Assim, após a padronização de um modelo de hipóxia em peixe-zebra, que demonstra danos relacionados à isquemia, nós testamos se essa concentração de DEDTC poderia ser neuroprotetora sobre este modelo. Contudo, DEDTC apresentou efeitos pró-oxidantes, embora ele tenha atenuado o elevado conteúdo de Zn reativo induzido pela hipóxia. Portanto, mesmo que o DEDTC tenha falhado, este modelo, agora, está apto para a triagem de outros fármacos com potencial ação sobre o alterado conteúdo de Zn reativo que ocorre em eventos hipóxicos-isquêmicos. / The content of brain reactive zinc (Zn) is important for the synaptophysiology in the central nervous system (CNS). This is evidenced in hypoxic-ischemic events, when an increase in their levels results in neurotoxicity. Consequently, this has stimulated the treatment of cerebral ischemia with Zn chelators, such as diethyldithiocarbamate (DEDTC). In the case of DEDTC, the use of this compound in this dysfunction should be examined carefully, because it also has many side effects on the (CNS). Thus, to meet this, it is necessary first to obtain a concentration of DEDTC with negligible side effects. Here, we decided to use a simpler vertebrate model, such as zebrafish, which would allow large-scale screening of DEDTC effects on reactive Zn. However, the presence of reactive Zn has never been shown in zebrafish brain. Then, using histological markers, we were able to show for the first time the cytoarchitectonic distribution of reactive Zn in glutamatergic neurons as well as the number of these neurons containing Zn in the zebrafish brain. This allowed us to evaluate the effect of different DEDTC concentrations on the brain content of Zn in zebrafish. As a result, high levels of the compound did strongly chelate the metal, inducing seizure-like behaviors. In this study we also obtained a DEDTC concentration with few side effects that could exert neuroprotection on the increased reactive Zn induced by hypoxia-ischemia. Then, after the standardization of an ischemic-sensitive model of hypoxia in zebrafish, we tested if this DEDTC concentration could be neuroprotective on this model. Nevertheless, DEDTC showed pro-oxidant effects, though it had mitigated the elevated content of reactive Zn induced hypoxia. Therefore, despite the DEDTC have failed as neuroprotective drug, this model enables the screening of other chemical agents with potential action on the increased content of reactive Zn that occurs in hypoxic-ischemic events.

Vitamin A is an essential nutrient; it is not synthesized by mammals and therefore must be obtained through the diet. During times of fasting or dietary vitamin A insufficiency, retinol, the alcohol form of the vitamin is released from the liver, its main storage tissue, for circulation in complex with retinol-binding protein 4 (RBP) to provide an adequate supply to peripheral tissues. Stimulated by Retinoic Acid 6 (STRA6), the transmembrane RBP receptor, mediates retinol uptake across blood-tissue barriers such as the retinal pigment epithelium of the eye, the placenta and the choroid plexus of the brain. Our understanding as to how this protein functions has been greatly enhanced by the high-resolution 3D structure of zebrafish STRA6 in complex with calmodulin (CaM) solved by single-particle cryogenic-electron microscopy. However, the nature of the interaction of STRA6 with retinol remains unclear. Here, I present the high-resolution structures of zebrafish and sheep STRA6 reconstituted in nanodisc lipid bilayers in the presence and absence of retinol. The nanodisc reconstitution system has allowed us to study this protein in a close to physiological environment and examine its interaction with the cell membrane and relationship with its ligand, retinol. We also present the structure of sheep STRA6 in complex with human RBP. The structure of the STRA6-RBP complex confirms predictions in the literature as to the nature of the protein-protein interaction needed for retinol transport. Calcium-bound CaM is bound to STRA6 in the RBP-STRA6 structure, consistent with a regulatory role of this calcium binding protein in STRA6-RBP interaction. The analysis of the three states of STRA6 – pre, post and during interaction with retinol – provide unique insights into the mechanism of STRA6-mediated cellular retinol uptake.

Orientador: Cristiane Angélica Ottoni / Resumo: A utilização de nanopartículas de prata (AgNP) biológicas nos dias atuais é uma alternativa promissora frente as obtidas por via sintética (VS), uma vez que, não geram resíduos em seu processo de síntese e possuem superfície revestida por proteínas que viabilizam sua incorporação em diversos compostos comerciais, sendo os fármacos os de maior destaque. O efeito do descarte de AgNP sintéticas no meio ambiente é atualmente fonte de investigação de diversos grupos de pesquisa, entretanto, são restritas as informações associadas as AgNP biológicas. Diante deste contexto, o presente estudo utilizou a AgNP IBCLP20 biossintetizada pelo fungo Aspergillus niger para avaliar a sua ação antimicrobiana e efeito tóxico em ambiente aquático dulcícula utilizando organismos pertencentes a diferentes níveis tróficos. Nos ensaios antimicrobianos a AgNP IBCLP20 apresentou excelente ação antibacteriana em uma faixa de concentração de 5 a 100 µg/mL e ação antifúngica na faixa de concentração de 20 a 100 µg/mL. A densidade celular da microalga Chrorella vulgaris, quando exposta a AgNP IBCLP20 e ao sal precursor AgNO3, na maior concentração analisada (100 uM/mL) e após 96 horas de incubação, apresentou uma taxa de redução de 34,4% e 85,71%, respectivamente. Nas mesmas condições supracitadas, só foi detectada viabilidade celular da microalga quando exposta a AgNP biológica (65,38%). A letalidade média em D. silimis causada pelas AgNP IBCLP20 foi estimada a uma concentração de 4,06 μg/L (2,29 -6,42).... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: The use of biological silver nanoparticles (AgNP) today is a promising alternative compared to those obtained synthetically (VS), since they do not generate residues in their synthesis process and have a surface coated with proteins that enable their incorporation in several commercial compounds, with drugs being the most prominent. The effect of discarding synthetic AgNP in the environment is currently a source of investigation for several research groups, however, information associated with biological AgNP is restricted. In this context, the present study used the AgNP IBCLP20 biosynthesized by the fungus Aspergillus niger to evaluate its antimicrobial action and toxic effect in aquatic dulcicle environment using organisms belonging to different trophic levels. In antimicrobial tests, AgNP IBCLP20 showed excellent antibacterial action in a concentration range of 5 to 100 µg / mL and antifungal action in the concentration range of 20 to 100 µg / mL. The cell density of the microalgae Chrorella vulgaris, when exposed to AgNP IBCLP20 and the precursor salt AgNO3, in the highest concentration analyzed (100 uM / mL) and after 96 hours of incubation, showed a reduction rate of 34.4% and 85.71 %, respectively. Under the same conditions mentioned above, cell viability of the microalgae was only detected when exposed to biological AgNP (65.38%). The average lethality in D. silimis caused by AgNP IBCLP20 was estimated at a concentration of 4.06μg/L (2.29 -6.42). , The physiological ... (Complete abstract click electronic access below) / Mestre

Thrombocytes are functional equivalents of mammalian platelets and also possess megakaryocyte features. It has been shown earlier that hox genes play a role in megakaryocyte development. Our earlier microarray analysis showed five hox genes, hoxa10b, hoxb2a, hoxc5a, hoxc11b and hoxd3a, were upregulated in zebrafish thrombocytes. However, there is no comprehensive study of genome wide scan of all the hox genes playing a role in megakaryopoiesis. I first measured the expression levels of each of these hox genes in young and mature thrombocytes and observed that all the above hox genes except hoxc11b were expressed equally in both populations of thrombocytes. hoxc11b was expressed only in young thrombocytes and not in mature thrombocytes. The goals of my study were to comprehensively knockdown hox genes and identify the specific hox genes involved in the development of thrombocytes in zebrafish. However, the existing vivo-morpholino knockdown technology was not capable of performing such genome-wide knockdowns. Therefore, I developed a novel cost- effective knockdown method by designing an antisense oligonucleotides against the target mRNA and piggybacking with standard control morpholino to silence the gene of interest. Also, to perform knockdowns of the hox genes and test for the number of thrombocytes, the available techniques were both cumbersome or required breeding and production of fish where thrombocytes are GFP labeled. Therefore, I established a flow cytometry based method of counting the number of thrombocytes. I used mepacrine to fluorescently label the blood cells and used the white cell fraction. Standard antisense oligonucleotide designed to the central portion of each of the target hox mRNAs, was piggybacked by a control morpholino and intravenously injected into the adult zebrafish. The thrombocyte count was measured 48 hours post injection. In this study, I found that the knockdown of hoxc11b resulted in increased number of thrombocytes and knockdown of hoxa10b, hoxb2a, hoxc5a, and hoxd3a showed reduction in the thrombocyte counts. I then screened the other 47 hox genes in the zebrafish genome using flow sorting method and found that knockdown of hoxa9a and hoxb1a also resulted in decreased thrombocyte number. Further, I used the dye DiI, which labels only young thrombocytes at specific concentrations and observed that the knockdown of hoxa10b, hoxb2a, hoxc5a, hoxd3a, hoxa9a and hoxb1a, lead to a decrease in young thrombocytes; whereas hoxc11b knockdown lead to increase in number of young thrombocytes. Using bromodeoxyuridine, I also showed that there is increase in release of young thrombocytes into peripheral circulation in hoxc11b knockdown fish which suggests that hoxc11b significantly promotes cell proliferation rather effecting apoptosis. In conclusion, I found six hox genes that are positive regulators and one hox gene is a negative regulator for thrombocyte development.

GPR17, a uracil nucleotide cysteinyl leukotriene receptor, belongs to the GPCR (G protein coupled receptor) family. It has been shown recently that inhibiting this protein in the nervous system in mice can lead to blockage of oligodendrocyte maturation, which supports myelin repair. Interestingly, our laboratory found GPR17 in thrombocytes. However, we do not know whether it has any function in thrombocyte aggregation or the nature of the ligand. In this paper, we studied the role of GPR17 in hemostasis, which is a fundamental defense mechanism in the event of injury. Using zebrafish as a model system, our laboratory has studied specifically thrombocytes, which play a significant role in hemostasis. The major reasons to use zebrafish as a model system are that their thrombocytes are functionally equivalent to human platelets, the adult fish are amenable to knockdown experiments, and they are readily available in the market. This study was performed by using a piggy back knockdown method where we used a chemical hybrid of control morpholino and an antisense oligonucleotide sequence leads to the degradation the mRNA for GPR17. After knockdown GPR17 in thrombocytes, the percent difference of the thrombocytes aggregation between the control and knockdown blood samples was measured by flow cytometry. We used various thrombocyte agonists to study differences in aggregation between the control and knockdown blood samples. The study showed that knockdown of GPR17 resulted in no significant differences in percent thrombocyte aggregation between control and agonist treated samples except for a slight increase in collagen-treated samples. Thus, it appears that GPR17 has no significant role in hemostasis.

No description available.

No description available.

No description available.